Cargando…
Statistical genetics and polygenic risk score for precision medicine
The prediction of disease risks is an essential part of personalized medicine, which includes early disease detection, prevention, and intervention. The polygenic risk score (PRS) has become the standard for quantifying genetic liability in predicting disease risks. PRS utilizes single-nucleotide po...
Autores principales: | Konuma, Takahiro, Okada, Yukinori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212479/ https://www.ncbi.nlm.nih.gov/pubmed/34140035 http://dx.doi.org/10.1186/s41232-021-00172-9 |
Ejemplares similares
-
Testing the application of polygenic risk scores in the transplant setting – Relevance for precision medicine
por: Shaked, Abraham, et al.
Publicado: (2022) -
Integration of genetically regulated gene expression and pharmacological library provides therapeutic drug candidates
por: Konuma, Takahiro, et al.
Publicado: (2021) -
Polygenic risk scores: the future of cancer risk prediction, screening, and precision prevention
por: Wang, Yuzhuo, et al.
Publicado: (2022) -
Role of Polygenic Risk Score in Cancer Precision Medicine of Non-European Populations: A Systematic Review
por: Junior, Howard Lopes Ribeiro, et al.
Publicado: (2022) -
Genetic Risk Scores for Diabetes Diagnosis and Precision Medicine
por: Udler, Miriam S, et al.
Publicado: (2019)